Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data

Sawalha Y, Maddocks K

OncoTargets and Therapy 2020, 13:5123-5133

Published Date: 8 June 2020